Cargando…

Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse

Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have an irreplaceable role in the treatment of myocardial infarction (MI), which can be injected into the transplanted area with new cardiomyocytes (Cardiomyocytes, CMs), and improve myocardial function. However, the immaturity of the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Peng, Sai, Xiyalatu, Li, Zhetao, Ye, Xing, Jin, Li, Liu, Guihuan, Li, Ge, Yang, Pingzhen, Zhao, Mingyi, Zhu, Shuoji, Liu, Nanbo, Zhu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167678/ https://www.ncbi.nlm.nih.gov/pubmed/35702609 http://dx.doi.org/10.1016/j.bioactmat.2022.05.024

Ejemplares similares

Immunomodulatory effects of icariin in a myocardial infarction mouse model
por: Sai, Xiyalatu, et al.
Publicado: (2022)

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021)

Injectable conductive gelatin methacrylate / oxidized dextran hydrogel encapsulating umbilical cord mesenchymal stem cells for myocardial infarction treatment
por: Zhu, Shuoji, et al.
Publicado: (2021)

Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m(6)A modification of Trio mRNA
por: Li, Jiaxin, et al.
Publicado: (2022)

Impact of extracellular matrix on engraftment and maturation of pluripotent stem cell-derived cardiomyocytes in a rat myocardial infarct model
por: Ogasawara, Tatsuki, et al.
Publicado: (2017)

Screening Genes Promoting Exit from Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout
por: Yang, Bin, et al.
Publicado: (2020)

Cardiovascular Disease and Exercise: From Molecular Mechanisms to Clinical Applications
por: Wang, Bo, et al.
Publicado: (2022)

Retraction: Wang et al. Cardiovascular Disease and Exercise: From Molecular Mechanisms to Clinical Applications. J. Clin. Med. 2022, 11, 7511
por: Wang, Bo, et al.
Publicado: (2023)

Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
por: Xiao, Yang, et al.
Publicado: (2022)

Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
por: Ge, Feixiang, et al.
Publicado: (2019)

Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes
por: Zhu, Renjun, et al.
Publicado: (2014)

Single-cell analysis of graft-infiltrating host cells identifies caspase-1 as a potential therapeutic target for heart transplant rejection
por: Wu, Zhichao, et al.
Publicado: (2023)

Transferrin improved the generation of cardiomyocyte from human pluripotent stem cells for myocardial infarction repair
por: Zhang, Fengzhi, et al.
Publicado: (2020)

S-allyl-cysteine sulfoxide (alliin) alleviates myocardial infarction by modulating cardiomyocyte necroptosis and autophagy
por: Yue, Li-Jun, et al.
Publicado: (2019)

Maturation of pluripotent stem cell derived cardiomyocytes: The new challenge
por: Aigha, Idil, et al.
Publicado: (2016)

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
por: Dai, Dao-Fu, et al.
Publicado: (2017)

Nogo-C regulates cardiomyocyte apoptosis during mouse myocardial infarction
por: Jia, Shi, et al.
Publicado: (2016)

Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming
por: Huang, Ping, et al.
Publicado: (2021)

Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
por: Liu, Nanbo, et al.
Publicado: (2020)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
por: Chen, Rou, et al.
Publicado: (2019)

Construction of multifunctional hydrogel with metal-polyphenol capsules for infected full-thickness skin wound healing
por: Liu, Nanbo, et al.
Publicado: (2022)

Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Sun, Xuetao, et al.
Publicado: (2017)

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
por: Machiraju, Pranav, et al.
Publicado: (2019)

Optimal transplantation strategy using human induced pluripotent stem cell‐derived cardiomyocytes for acute myocardial infarction in nonhuman primates
por: Li, Hong‐mei, et al.
Publicado: (2023)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes
por: Jiang, Xin, et al.
Publicado: (2020)

Mussel-inspired conductive Ti(2)C-cryogel promotes functional maturation of cardiomyocytes and enhances repair of myocardial infarction
por: Ye, Genlan, et al.
Publicado: (2020)

CircRNA ACAP2 Is Overexpressed in Myocardial Infarction and Promotes the Maturation of miR-532 to Induce the Apoptosis of Cardiomyocyte
por: Zhang, Jun, et al.
Publicado: (2021)

Trajectory reconstruction identifies dysregulation of perinatal maturation programs in pluripotent stem cell-derived cardiomyocytes
por: Kannan, Suraj, et al.
Publicado: (2023)

Activation of AMPK Promotes Maturation of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
por: Ye, Liang, et al.
Publicado: (2021)

Editorial: Cardiomyocyte Maturation: Novel Insights for Regenerative Medicine
por: Zhang, Min, et al.
Publicado: (2021)

Cardiomyocytes Cellular Phenotypes After Myocardial Infarction
por: Lodrini, Alessandra Maria, et al.
Publicado: (2021)

Biowire: a new platform for maturation of human pluripotent stem cell derived cardiomyocytes
por: Nunes, Sara S., et al.
Publicado: (2013)

Levosimendan Postconditioning Attenuates Cardiomyocyte Apoptosis after Myocardial Infarction
por: Xie, Ying, et al.
Publicado: (2022)

Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct
por: Vuorenpää, Hanna, et al.
Publicado: (2017)

Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells
por: Funakoshi, Shunsuke, et al.
Publicado: (2021)

Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction
por: Zhao, Xin, et al.
Publicado: (2018)

Comparison of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes with Human Mesenchymal Stem Cells following Acute Myocardial Infarction
por: Citro, Lucas, et al.
Publicado: (2014)

Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and Limitations
por: Jiang, Yanqing, et al.
Publicado: (2018)

Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Bhute, Vijesh J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uqnvc9ta9k4uch3dt0qcfdcuij